Meet us at CTAD 2026 in Boston, 16–⁠19 November: poster P446 on phone changes and speech measures. Find us in Boston ›

Fixed scopes, starting with a re‑analysis pilot

Coarse scales, few visits, rater variation and phone changes hide drug effects. Cephalgo adds rater checks and readings on your scale, stable across phone changes, from audio you hold, site visits or home. Fixed fee.

Starting points

Where you start

Four starting points. For rated interviews, Trial QC can also run on its own. Trial QC ›

Recordings from a past or ongoing trial

Your visit and interview audio has never been read for speech. You get readings on your scale, rater flags and variance components, and from a completed trial an effect size your statistician computes on the locked readings. No new collection. Re-analysis pilot ›

No audio yet

You get readings from the site’s own visit recordings and short home sessions, pre-specified in your SAP, so a change can be seen between scheduled visits. Home sessions run in your eCOA or app; ours only where none exists. Prospective study ›

Already using a speech vendor

You get a second reading on your existing audio, on the trial’s own scale, so a vendor-only finding can be confirmed before it drives a decision. Your vendor stays. Re-analysis pilot › Stability audit ›

Already running your own speech models

Keep your pipeline. You get readings on your scale and named features on the same audio, so you can test your own measures against them. Re-analysis pilot › Stability audit ›

See the scopes
1 · Lowest-risk start

Re-analysis pilot

Your completed or ongoing study already holds recorded speech. You get an extra measure from it and, from a completed trial, effect sizes for your next protocol, where consent covers further analysis. No new collection or protocol change.

On your scale

A reading per visit on the protocol’s scale. Calibrated on the study’s screening and baseline ratings, blind to arm, and locked before post-baseline recordings are read.

Joined to the visit score

Readings and visit scores in one table, visit by visit, ready for your statisticians.

Trial QC flags included

Where the recordings are rating interviews, Trial QC flags per rater and interview, as in the Trial QC scope.

Sample-size planning

From a completed study: variance components and an effect-size estimate, computed by your statistician on the locked readings. Cephalgo’s analysis team stays blind to arm.

You send
  • Recordings, or your authorization to their holder; Cephalgo drafts it
  • Visit scores
  • The consent scope
  • Fee and timeline: fixed in writing before any data moves
Request a re-analysis pilot
2 · On rated interviews

Trial QC

Baseline inflation and rater drift add noise that reads as placebo response. For a trial whose endpoint is a rated interview, you get flags from screening onward, so your blinded team can act before randomization.

Flags per rater and interview

Each score checked against the recorded interview, the rater’s own other interviews, and other sites at the same visit type.

Before randomization

Screening interviews are read as they arrive, so a flag can reach your blinded team before randomization; baseline interviews are flagged by the next data transfer.

Flag rule fixed first

Set in writing before any audio is read. A between-arm check is pre-specified and run by an independent unblinded statistician; its results never reach the team that receives flags.

Who receives flags

Your blinded study team or central rating vendor, at each data transfer.

A rating interview at a study site
You send
  • Recorded rating interviews from your sites, eCOA or central rating vendor
  • Your authorization to the recording holder; Cephalgo drafts it, sends a one-page file specification and coordinates retrieval
3 · Written into the protocol

Prospective study

Few coarse visits leave little data for phase 2 decisions, including dose. For a protocol in design, you get site-visit and home readings per participant, pre‑specified in your SAP. Your team sees pooled readings; per‑arm readings stay in an unblinded view.

Capture specification

Recording tasks, cadence and consent wording, ready for the protocol and your eCOA or app vendor; our capture runs home sessions only where the study has none.

Exploratory endpoint

Pre-specified in your SAP; estimand, features and comparison drafted with your statisticians per ICH E9(R1).

Participants’ own devices

Readings recalibrated when a phone or its software changes. Device, software and app version where the recording app provides them; otherwise the processing period, read from the audio.

Into your systems

Readings by export, by API or into the study’s eCOA or EDC system.

Request a prospective scope
A participant recording a short task at home
You send
  • The draft protocol: phase, population and endpoint
4 · Across device changes

Stability audit

Phones and their software change during a study, and a change can look like disease change. You get each reading checked and recalibrated across those changes, so readings from every device and software version sit on one scale.

Processing periods

Where, in each participant’s recordings, the phone or its software changes, from version data or read from the audio.

Stability per reading

How stable each reading and its named features are across those periods.

Original and recalibrated

Both sets of readings across the periods, recalibrated blind to arm, for your analysis.

Nothing new to collect

Runs on the recordings you already hold, within the consent they were collected under; no protocol change.

Device changes ›

Request a stability audit scope
Separate scope

Pre-screening

Screen failures cost site time and budget. You get a reading against your entry criteria, recorded at home before the screening visit, so sites can book screening visits for candidates inside your entry range. The entry scale is set per program.

Entry range fixed first

Calibrated per study language on paired screening scores and recordings, and fixed in writing before the first candidate records.

Consent

Candidates consent to pre-screening, remotely where approved; trial consent stays at the screening visit. Recordings of those not invited are kept only as the protocol and consent specify.

Reading returned

To the site through the study dashboard, as set in the written scope. Any safety disclosure in a recording goes to the site, under your protocol’s safety procedure. Platform ›

Recording route

A browser on the candidate’s own phone, an automated or site-run phone call, or our app. A failed check gets a retake before the session ends. Recording routes ›

Request a pre-screening scope
  1. 01
    Site

    Refers and consents

    Pre-screening consent, apart from trial consent

  2. 02
    Candidate

    Records a few minutes

    App, browser or phone call

  3. 03
    Cephalgo

    Checks and reads

    Against the entry range

  4. 04
    Cephalgo

    Returns the reading

    Before the site books the screening visit

  5. 05
    Site

    Invites and screens

    The site decides who is invited. The screening visit is unchanged.

You send
  • The program, the entry criteria and the number of sites
Site burden

What each scope asks of sites and participants

What changes for participants and site staff, scope by scope. Where a scope adds work at sites, one remote training workshop comes before activation.

Request a scope
ScopeParticipantSite staff
Re-analysis pilotNothing newNothing new
Trial QCSites already recordingNothing newNothing new
Trial QCSites not yet recordingInterview recorded under the protocol, with consent from participants and informantsInterview recording added, with one remote training workshop; the scale administered and scored as before
Prospective studySite-visit recordings and short home sessions between visits, at the cadence the protocol setsOne remote training workshop; scale, raters and visit schedule unchanged
Stability auditNothing newNothing new
Pre-screeningSeparate scopeA few minutes at home, by app or browser on the candidate’s own device, or by a phone callRefers and consents; may run the phone call; reviews readings outside the entry range
Deliverables in every scope

What you hold at the end

Readings or Trial QC flags, versions and evidence in the formats your study already uses, with GDPR documents and records designed to support 21 CFR Part 11 in every scope.

Readings and flags

Readings per session or visit, and Trial QC flags per rater and interview, as CSV, Parquet or API, or into your eCOA or EDC; CDISC ODM, SDTM-aligned or your format.

Version record

Analysis version on every reading; device, software and app version where the recording app provides them, otherwise the processing period, read from the audio.

Analysis plan text

Estimand, features and comparison, fixed in writing before post‑baseline recordings are read; the Trial QC flag rule, before any audio is read.

Validation evidence

Each measure evaluated stage by stage following the DiMe V3 framework, one indication at a time, and your study’s validation report follows TRIPOD+AI. Validation approach ›

Vendor qualification

Scope your first study with our team

Bring the phase, population and endpoint, and any audio you already hold.

Request

We use your work email to send you the document and to follow up about it and related work. You can opt out at any time. Privacy policy

Thank you. We will send it to your work email.

Something went wrong. Please write to contact@cephalgo.com.